MedTrace Logo

Spot Drug-Eluting Stenting for Long Coronary Stenoses

NCT00738556 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 179

Last updated 2009-01-29

No results posted yet for this study

Summary

Most doctors who use the new drug-eluting stents for the treatment of long coronary narrowings tend to cover the full length of the lesion with long or multiple stents. The investigators hypothesized that a policy of spot-stenting, i.e., stenting of only the very tight parts of the coronary narrowing, might result in better outcomes by means of avoiding multiple stents that have been associated with significant complications such as late stent thrombosis.

Conditions

  • Angioplasty

Interventions

DEVICE

Drug-eluting stents (Cypher and Taxus)

Spot or full length stenting of a coronary lesion

Sponsors & Collaborators

  • Cardiovascular Research Society, Greece

    lead OTHER

Principal Investigators

  • Demosthenes Katritsis, MD, PhD · Athens Euroclinic and Cardiovasdcular Research Society

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00738556 on ClinicalTrials.gov